BR0014444A - Prv-1 gene and its use - Google Patents
Prv-1 gene and its useInfo
- Publication number
- BR0014444A BR0014444A BR0014444-4A BR0014444A BR0014444A BR 0014444 A BR0014444 A BR 0014444A BR 0014444 A BR0014444 A BR 0014444A BR 0014444 A BR0014444 A BR 0014444A
- Authority
- BR
- Brazil
- Prior art keywords
- gene
- prv
- sequence
- encodes
- protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Patente de Invenção: "GENE PRV-1 E USO DO MESMO". Este documento descreve uma seq³ência de nucleotídeos que codifica a proteína PRV-1 e compreende essencialmente a seq³ência ID NN<0>: 1 e também um processo para a detecção deste gene [lacuna] o mRNA codificado por este gene e o polipeptídeo codificado por este gene.Invention Patent: "GENE PRV-1 AND USE OF THE SAME". This document describes a nucleotide sequence that encodes the PRV-1 protein and essentially comprises the sequence ID NN <0>: 1 and also a process for the detection of this gene [gap] the mRNA encoded by this gene and the polypeptide encoded by it gene.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19947010A DE19947010A1 (en) | 1999-09-30 | 1999-09-30 | The PRV-1 gene and its use |
PCT/EP2000/009594 WO2001023554A1 (en) | 1999-09-30 | 2000-09-29 | The prv-1 gene and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0014444A true BR0014444A (en) | 2002-06-11 |
Family
ID=7923937
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0014444-4A BR0014444A (en) | 1999-09-30 | 2000-09-29 | Prv-1 gene and its use |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP1220920A1 (en) |
JP (1) | JP2003510077A (en) |
KR (1) | KR20020047191A (en) |
CN (1) | CN1377408A (en) |
AU (1) | AU1132401A (en) |
BG (1) | BG106554A (en) |
BR (1) | BR0014444A (en) |
CA (1) | CA2387702A1 (en) |
CZ (1) | CZ20021094A3 (en) |
DE (1) | DE19947010A1 (en) |
EA (1) | EA200200286A1 (en) |
EE (1) | EE200200168A (en) |
HR (1) | HRP20020269A2 (en) |
HU (1) | HUP0203080A2 (en) |
IL (1) | IL148770A0 (en) |
MX (1) | MXPA02002800A (en) |
NO (1) | NO20021498L (en) |
PL (1) | PL354184A1 (en) |
SK (1) | SK4262002A3 (en) |
WO (1) | WO2001023554A1 (en) |
ZA (1) | ZA200202379B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL158599A0 (en) * | 2003-10-26 | 2004-05-12 | Yeda Res & Dev | Methods of modulating hematopoiesis |
BR112014028838A2 (en) | 2012-05-21 | 2020-05-12 | Genentech Inc | USES OF AN ANTIBODY, METHOD FOR MAKING AN ANTIBODY AND ANTIBODIES |
WO2018229179A1 (en) * | 2017-06-14 | 2018-12-20 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000036102A2 (en) * | 1998-12-16 | 2000-06-22 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
EP0991757A1 (en) * | 1997-05-06 | 2000-04-12 | ZymoGenetics | Novel tumor antigens |
CA2328895A1 (en) * | 1998-06-02 | 1999-12-09 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
DE19849044A1 (en) * | 1998-10-23 | 2000-04-27 | Univ Ludwigs Albert | New polycythemia rubra vera-related polypeptide useful for diagnosis and for developing therapeutic antibodies |
-
1999
- 1999-09-30 DE DE19947010A patent/DE19947010A1/en not_active Withdrawn
-
2000
- 2000-09-29 WO PCT/EP2000/009594 patent/WO2001023554A1/en not_active Application Discontinuation
- 2000-09-29 BR BR0014444-4A patent/BR0014444A/en not_active Application Discontinuation
- 2000-09-29 CA CA002387702A patent/CA2387702A1/en not_active Abandoned
- 2000-09-29 MX MXPA02002800A patent/MXPA02002800A/en unknown
- 2000-09-29 AU AU11324/01A patent/AU1132401A/en not_active Abandoned
- 2000-09-29 CZ CZ20021094A patent/CZ20021094A3/en unknown
- 2000-09-29 CN CN00813580A patent/CN1377408A/en active Pending
- 2000-09-29 JP JP2001526936A patent/JP2003510077A/en active Pending
- 2000-09-29 IL IL14877000A patent/IL148770A0/en unknown
- 2000-09-29 HU HU0203080A patent/HUP0203080A2/en unknown
- 2000-09-29 SK SK426-2002A patent/SK4262002A3/en unknown
- 2000-09-29 EE EEP200200168A patent/EE200200168A/en unknown
- 2000-09-29 EP EP00972665A patent/EP1220920A1/en not_active Withdrawn
- 2000-09-29 KR KR1020027004095A patent/KR20020047191A/en not_active Application Discontinuation
- 2000-09-29 PL PL00354184A patent/PL354184A1/en not_active IP Right Cessation
- 2000-09-29 EA EA200200286A patent/EA200200286A1/en unknown
-
2002
- 2002-03-25 ZA ZA200202379A patent/ZA200202379B/en unknown
- 2002-03-26 NO NO20021498A patent/NO20021498L/en not_active Application Discontinuation
- 2002-03-27 BG BG106554A patent/BG106554A/en unknown
- 2002-03-28 HR HR20020269A patent/HRP20020269A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1220920A1 (en) | 2002-07-10 |
CN1377408A (en) | 2002-10-30 |
KR20020047191A (en) | 2002-06-21 |
AU1132401A (en) | 2001-04-30 |
NO20021498L (en) | 2002-05-23 |
BG106554A (en) | 2003-01-31 |
HRP20020269A2 (en) | 2003-06-30 |
NO20021498D0 (en) | 2002-03-26 |
PL354184A1 (en) | 2003-12-29 |
JP2003510077A (en) | 2003-03-18 |
MXPA02002800A (en) | 2002-07-22 |
EA200200286A1 (en) | 2002-12-26 |
IL148770A0 (en) | 2002-09-12 |
HUP0203080A2 (en) | 2002-12-28 |
SK4262002A3 (en) | 2002-09-10 |
CA2387702A1 (en) | 2001-04-05 |
CZ20021094A3 (en) | 2002-06-12 |
ZA200202379B (en) | 2003-10-29 |
WO2001023554A1 (en) | 2001-04-05 |
EE200200168A (en) | 2003-04-15 |
DE19947010A1 (en) | 2001-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1508574A3 (en) | Long wavelength engineered fluorescent proteins | |
CY1106806T1 (en) | DNA AND HUMAN TSLP POLYPEPTIDES | |
EP1067182A8 (en) | Secretory protein or membrane protein | |
BR9915604A (en) | Tgfbeta1 inhibitory peptides | |
ATE394484T1 (en) | SMAD 6 AND ITS APPLICATIONS | |
BR9909918A (en) | Method for the release of a physiologically active growth hormone or protein cytokine, peptide or polypeptide to a non-human vertebrate | |
ATE495247T1 (en) | CHROMOPROTEIN AND FLUOROPROTEINS | |
BR9902377A (en) | Composition for toner and processes for it. | |
DK1028744T3 (en) | Neuronal applications of BMP-11 | |
BR0014444A (en) | Prv-1 gene and its use | |
AU762955C (en) | Methods and compositions useful for modulation of angiogenesis using tyrosine kinase SRC | |
DK0773999T3 (en) | OR-1, an orphan receptor belonging to the nuclear receptor family | |
ITMC20020011A1 (en) | METHOD AND RELATED SYSTEM FOR LASER ENGRAVING OF SLABS OR CYLINDRICALCOGRAPHS. | |
BR9915537A (en) | Prv-1 gene and its use | |
NO20014691D0 (en) | Seat-specific, isotope-labeled proteins, amino acids and biochemical precursors for such | |
WO2004003170A3 (en) | Agents capable of inhibiting ras and uses thereof | |
ATE328082T1 (en) | SHORTENED BARD1 PROTEIN AND ITS DIAGNOSTIC AND THERAPEUTIC APPLICATIONS | |
DK1360306T3 (en) | DNA sequence of the enzyme phospholipase A1 from ciliate Tetrahymena and its use | |
EP0911408A3 (en) | DNA coding for serine/threonine kinase | |
GB0113920D0 (en) | Composition | |
ITRM950434A0 (en) | POLYPEPTIDE FOR THE REPAIR OF GENETIC INFORMATION, NUCLEOTIDE SEQUENCE THAT CODES FOR IT AND PROCEDURE FOR ITS PREPARATION. | |
BR9811501A (en) | Nucleotide sequence of the oropouche virus nucleocapsid gene | |
WO2002038765A3 (en) | Dna encoding bovine immunoglobulin a inducing protein and uses therefor | |
BR0100232A (en) | Levodione reductase gene and use of it | |
BR9912183A (en) | Angiotensin receptor, preparation and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |